Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal

American Journal of Tropical Medicine and Hygiene

Volumn 63, Issue 3-4, 2000, Pages 153-157

  Bern, Caryn ^a   Jha, Shambhu Nath ^c   Joshi, Anand B ^b   Thakur, G D ^c   Bista, Mahendra Bahadur ^d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b TRIBHUVAN UNIVERSITY   (Nepal)

^c Vec Borne Dis Res and Train Ctr   (Nepal)

^d Minister for Health and Population Nepal   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; RECOMBINANT ANTIGEN; RECOMBINANT K39 ANTIGEN; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ANTIBODY DETECTION; ARTICLE; BONE MARROW; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDEMIC DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEPAL; SEROLOGY; VISCERAL LEISHMANIASIS;

EID: 0034442410     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.63.153     Document Type: Article

References (25)

1. Herwaldt BL, 1999. Leishmaniasis. Lancet 354: 1191-1199.
2. Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, Ghalib HW, Kager PA, 1992. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg 86: 505-507.
3. el-Safi SH, Peters W, Evans DA, 1991. Studies on the leishmaniases in the Sudan. 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis. Trans R Soc Trop Med Hyg 85: 465-470.
4. Boelaert M, Lynen L, Desjeux P, Van der Stuyft P, 1999. Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull World Health Organ 77: 667-674.
5. Chowdhury MS, el Harith A, al Massum A, al Karim E, al Rahman A, 1993. Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities. Parasitol Res 79: 444-450.
6. Kager PA, Rees PH, 1983. Splenic aspiration. Review of the literature. Trop Geogr Med 35: 111-124.
7. Ministry of Health, B. P. Koirala Insititute of Medical Sciences, and the World Health Organization, 1998. Kala-azar in Nepal: principles, practice and public health perspectives. Bastola SP, Karki P, Rijal S, Gautam A, eds. National Workshop of Kalaazar. Dharan, Nepal: Ministry of Health, His Majesty's Government of Nepal.
8. Boelaert M, El Safi S, Jacquet D, de Muynck A, van der Stuyft P, Le Ray D, 1999. Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis. Am J Trop Med Hyg 60: 129-134.
9. Harith AE, Kolk AH, Kager PA, Leeuwenburg J, Faber FJ, Muigai R, Kiugu S, Laarman JJ, 1987. Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA. Trans R Soc Trop Med Hyg 81: 603-606.
10. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD Jr, 1986. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154: 1003-1011.
11. Badaro R, Benson D, Eulalio MC, Freire M, Cunha S, Netto EM, Pedral-Sampaio D, Madureira C, Burns JM, Houghton RL, David JR, Reed SG, 1996. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 173: 758-761.
12. Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW, 1998. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 351: 563-565.
13. Dhiman RC, Sen AB, 1991. Epidemiology of kala-azar in rural Bihar (India) using village as a component unit of study. Indian J Med Res 93: 155-160.
14. Nandy A, Neogy AB, Chowdhury AB, 1987. Leishmanin test survey in an endemic village of Indian kala-azar near Calcutta. Ann Trop Med Parasitol 81: 693-699.
15. Boelaert M, El Safi S, Mousa H, Githure J, Mbati P, Gurubacharya V, Shrestha J, Jacquet D, De Muynck A, Le Ray D, Van der Stuyft P, 1999. Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis. Trop Med Int Health 4: 31-37.
16. Schubach A, Haddad F, Oliveira-Neto MP, Degrave W, Pirmez C, Grimaldi G, Jr., Fernandes O, 1998. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 178: 911-914.
17. Zijlstra EE, el-Hassan AM, Ismael A, 1995. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 52: 299-305.
18. de Rossell RA, de Duran RJ, Rossell O, Rodriguez AM, 1992. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg 86: 251-253.
19. Singla N, Singh GS, Sundar S, Vinayak VK, 1993. Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India. Trans R Soc Trop Med Hyg 87: 276-278.
20. Sinha R, Sehgal S, 1994. Comparative evaluation of serological tests in Indian kala-azar. J Trop Med Hyg 97: 333-340.
21. Pal A, Mukerji K, Basu D, Naskar K, Mallick KK, Ghosh DK, 1991. Evaluation of direct agglutination test (DAT) and ELISA for serodiagnosis of visceral leishmaniasis in India. J Clin Lab Anal 5: 303-306.
22. Zijlstra E, Daifalla N, Kager P, Khalil E, El-Hassan A, Reed S, Ghalib H, 1998. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 5: 117-720.
23. Altintas N, Yolasigmaz A, Sakru N, Yazar S, Ertug S, Ozbel Y, 1998. A sero-epidemiological study of visceral leishmaniosis in Izmir District, Turkey. J Egypt Soc Parasitol 28: 389-394.
24. Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, Ghalib HW, Kager PA, 1991. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan. Trans R Soc Trop Med Hyg 85: 474-476.
25. Schaefer KU, Kurtzhals JA, Gachihi GS, Muller AS, Kager PA, 1995. A prospective sero-epidemiological study of visceral leishmaniasis in Baringo District, Rift Valley Province, Kenya. Trans R Soc Trop Med Hyg 89: 471-475.